Fingerprint
Dive into the research topics of 'Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically